2022

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance..

Chris Ebong, Asadu Sserwang, Jane Frances Namuganga, James Kapisi, Arthur Mpimbaza, Samuel Gonahasa, Victor Asua, Sam Gudoi, Ruth Kigozi, James Tibenderana, John Bosco Bwanika, Agaba Bosco, Denis Rubahika, Daniel Kyabayinze, Jimmy Opigo, Damian Rutazana, Gloria Sebikaari, Kassahun Belay, Mame Niang, Eric S. Halsey, Leah F. Moriarty, Naomi W. Lucchi, Samaly S. Svigel Souza, Sam L. Nsobya, Moses R. Kamya & Adoke Yeka 2022

Subscribe to 2022

OUR PARTNERS

https://www.care-international.org/

https://www.usaid.gov/

https://www.oxfam.org/en

https://www.who.int/

https://cihr-irsc.gc.ca/e/27171.html

https://www.sida.se/en

https://www.gov.uk/world/organisations/dfid-uganda

https://www.goalglobal.org/

https://www.wvi.org/uganda

https://www.savethechildren.net/

https://amref.org/